Lunsiefar SRL
Lunsiefar reported total assets of 839,787 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jun 2026).
The score of Lunsiefar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lunsiefar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
Lunsiefar's financial analysis
- Solvency14.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lunsiefar
Lunsiefar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0800.136.865
- VAT number
- BE0800136865
- Peppol
- Registered · 0208:0800136865 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Mar 2023
- Registered office
- 3090 Overijse
- Latest accounts
- 2025 · filed on 10 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lunsiefar (SRL) has been based in Overijse since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 42,525 € and equity of 122,162 €; its revenue is not published. Its solvency stands at 14.5%, below the median of its sector (44.0%).
Companies similar to Lunsiefar
Companies in the same business, of comparable size and area, outside its group.
- Lotte Scheldeman Retail sale of pharmaceutical products Bornem · balance sheet 742,475 €
- Arklin Retail sale of pharmaceutical products Scherpenheuvel-Zichem · balance sheet 577,623 €
- Apkpharma Retail sale of pharmaceutical products Manage · balance sheet €1.05m
- geroFarma Retail sale of pharmaceutical products Kortrijk · balance sheet €1.05m
- VVD SRL Retail sale of pharmaceutical products Ixelles · balance sheet 956,770 €
- VdC Invest Retail sale of pharmaceutical products Lierde · balance sheet 660,114 €
- Apone Retail sale of pharmaceutical products Hemiksem · balance sheet 653,679 €
- Apotheek Valkenborg Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 879,426 €
Frequently asked questions about Lunsiefar
What is the revenue of Lunsiefar?
Lunsiefar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lunsiefar?
In Belgium, the VAT number is the company number prefixed with BE: BE0800136865 for Lunsiefar, if the company is VAT-registered. Its company number (CBE) is 0800.136.865.
Where is the registered office of Lunsiefar?
According to the CBE register, the registered office of Lunsiefar is in 3090 Overijse.
What is the equity of Lunsiefar?
At the close of the 2025 financial year, the equity of Lunsiefar amounts to 122,162 €, a solvency of 14.5% of total assets.
Who manages Lunsiefar?
The register lists 1 active mandates at Lunsiefar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lunsiefar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →